AC
Armistice Capital Portfolio holdings
AUM
$3.03B
1-Year Est. Return
36.06%
This Fund
S&P 500
1 Year Est. Return
+36.06%
AUM
$3.03B
AUM Growth
-$1.06B
(-26%)
Holding
457
Top Buys
| 1 | +$44.1M | |
| 2 | +$36.9M | |
| 3 | +$33.9M | |
| 4 |
MDLN
Medline Inc
MDLN
|
+$22.4M |
| 5 |
Meta Platforms (Facebook)
META
|
+$20.9M |
Top Sells
| 1 | +$70.6M | |
| 2 | +$56.5M | |
| 3 | +$53.6M | |
| 4 |
GE HealthCare
GEHC
|
+$53.1M |
| 5 |
PTC Therapeutics
PTCT
|
+$51.5M |
Sector Composition
| 1 | Healthcare | 71.05% |
| 2 | Technology | 13.53% |
| 3 | Consumer Discretionary | 7.9% |
| 4 | Communication Services | 2.94% |
| 5 | Consumer Staples | 2.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Energizer
ENR
$1.24B
| $19.7M | 0.65% |
1,200,000
+164,000
|
|
||
|
52
Meta Platforms (Facebook)
META
$1.57T
| $18.6M | 0.62% |
+32,594
|
|
||
53
4D Molecular Therapeutics
FDMT
$501M
| $18.6M | 0.61% |
2,000,000
+64,000
|
|
||
54
Microsoft
MSFT
$3.18T
| $18.1M | 0.6% |
48,860
-69,477
|
|
||
55
Edwards Lifesciences
EW
$49.8B
| $18M | 0.59% |
224,835
-52,643
|
|
||
56
Wynn Resorts
WYNN
$10.7B
| $17.6M | 0.58% |
173,545
-2,645
|
|
||
57
MacroGenics
MGNX
$268M
| $17.4M | 0.57% |
6,012,000
-312,000
|
|
||
58
Scholar Rock
SRRK
$5.33B
| $16.6M | 0.55% |
336,959
+136,959
|
|
||
|
BCYC
59
Bicycle Therapeutics
BCYC
$297M
| $15.8M | 0.52% |
3,398,000
+162,000
|
|
||
60
Central Garden & Pet Co Class A
CENTA
$2.11B
| $15.5M | 0.51% |
+478,000
|
|
||
61
Lennar Class A
LEN
$22B
| $15.4M | 0.51% |
177,013
+25,718
|
|
||
62
Toast
TOST
$14.6B
| $15.3M | 0.51% |
577,471
+349,718
|
|
||
63
Sanofi
SNY
$102B
| $14.5M | 0.48% |
300,000
-376,000
|
|
||
64
BILL Holdings
BILL
$3.54B
| $14.4M | 0.47% |
374,908
+103,519
|
|
||
65
UiPath
PATH
$6.05B
| $14.3M | 0.47% |
1,284,720
-239,897
|
|
||
66
Voyager Therapeutics
VYGR
$218M
| $13.5M | 0.45% |
3,500,000
-500,000
|
|
||
67
GSK
GSK
$99.2B
| $13M | 0.43% |
236,000
-764,000
|
|
||
68
Teradyne
TER
$64.4B
| $13M | 0.43% |
43,932
+15,630
|
|
||
69
Crocs
CROX
$5.92B
| $12.8M | 0.42% |
154,593
-35,757
|
|
||
70
Nike
NKE
$64.7B
| $12.5M | 0.41% |
236,540
-158,169
|
|
||
71
Bristol-Myers Squibb
BMY
$111B
| $12.4M | 0.41% |
205,024
-167,442
|
|
||
72
Vera Therapeutics
VERA
$2.21B
| $12M | 0.4% |
298,164
-355,632
|
|
||
|
BBOT
73
BridgeBio Oncology
BBOT
$645M
| $11.9M | 0.39% |
1,328,000
+328,000
|
|
||
74
Capri Holdings
CPRI
$2.11B
| $11.6M | 0.38% |
+658,000
|
|
||
|
NBIS
75
Nebius Group N.V.
NBIS
$66.5B
| $11.2M | 0.37% |
108,000
-159,421
|
|